Anti-PRRSV GP2 Polyclonal Antibody from ProteoGenix; catalogue ARO-A22478; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Introducing our Anti-PRRSV GP2 Polyclonal Antibody – the powerful tool for combating PRRSV infections in the biotech industry.
This highly specific antibody targets the glycoprotein 2 (GP2) of the Porcine Reproductive and Respiratory Syndrome Virus (PRRSV), a major threat to the global swine population. With its superior binding affinity and neutralizing activity, our Anti-PRRSV GP2 Polyclonal Antibody provides exceptional protection against PRRSV infections.
The Anti-PRRSV GP2 Polyclonal Antibody is produced from a pool of immune sera from animals immunized with the GP2 protein of PRRSV. It specifically recognizes and binds to the GP2 protein, preventing the virus from entering host cells and replicating. This antibody also triggers the immune response, leading to the production of neutralizing antibodies and enhancing the body’s ability to fight off PRRSV infections.
This antibody is a valuable tool for PRRSV research and diagnosis. It can be used in various immunoassays, including ELISA, Western blot, and immunofluorescence, to detect and quantify the presence of PRRSV in samples. Additionally, it can be used for in vitro neutralization assays to evaluate the efficacy of potential PRRSV vaccines or antivirals.
The Anti-PRRSV GP2 Polyclonal Antibody has been successfully used in numerous research studies and has shown promising results. In one study, it was used to develop a sensitive and specific ELISA for PRRSV detection in swine serum samples. In another study, it was used to evaluate the cross-reactivity of PRRSV strains from different geographical regions. Its high specificity and sensitivity make it an ideal choice for various experimental uses in PRRSV research.
In conclusion, our Anti-PRRSV GP2 Polyclonal Antibody is a crucial asset for the biotech industry in the fight against PRRSV infections. With its exceptional binding affinity and neutralizing activity, it provides reliable and accurate results for PRRSV detection and research. Don’t let PRRSV hinder your progress – choose our Anti-PRRSV GP2 Polyclonal Antibody for superior protection and results.
ProteoGenix catalogue number ARO-A22478. For research use only.
Target: GP2 glycosylated envelope protein, ORF2; Clonality: Polyclonal Antibody; Applications: IHC, ELISA, WB.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| GP2 glycosylated envelope protein, ORF2 |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
